Meropenem

25 NDCs across 10 manufacturers|25 Generic,0 Brand

Meropenem is used to treat appendicitis, bacteroides infections, escherichia coli infections, fever, klebsiella infections and haemophilus meningitis, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved on Jun 21, 1996, and the first generic was approved Jun 22, 2010. In 2024, Medicare Part D spent $17 million on Meropenem across 94,000 claims for 30,000 beneficiaries.

Meropenem is available as 25 NDCs from 10 manufacturers (25 generic, 0 brand), with NADAC prices from $2.87 to $4.67 per EA — a 63% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

25G / 0B

Manufacturers

competing in market

Price Spread

$2.87 – $4.67

per EA

7d Activity

13↓12 flat

avg -3.5% WoW · of 25 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Manufacturer Breakdown

10 manufacturers producing MEROPENEM(1 pricing outlier)

WG Critical Care, LLC

4 NDCs

$3.7682

avg/unit

Fresenius Kabi USA, LLC

4 NDCs

$3.7682

avg/unit

Hikma Pharmaceuticals USA Inc.

Amneal Pharmaceuticals LLC

2 NDCs

$3.7682

avg/unit

Xellia Pharmaceuticals USA LLC

Armas Pharmaceuticals Inc.

Drug Portfolio

25 NDCs total, 25 shown

Drug ↕	NDC	Manufacturer ↕	Price	Market Outlier	Class	7d Change ↕	Therapeutic Class
MEROPENEM IV 1 GM VIAL	00143943110	Hikma Pharmaceuticals USA Inc.	$4.6687 per EA	—	Generic	-3.51%	Penem Antibacterial
MEROPENEM IV 1 GM VIAL	00409139122	Hospira Inc.	$4.6687 per EA	—	Generic	-3.51%	Penem Antibacterial
MEROPENEM IV 1 GM VIAL	00409341210	Hospira Inc.	$4.6687 per EA	—	Generic	-3.51%	Penem Antibacterial
MEROPENEM IV 1 GM VIAL	00781309895	Sandoz Inc.	$4.6687 per EA	—	Generic	-3.51%	Penem Antibacterial
MEROPENEM IV 1 GM VIAL	44567014610	WG Critical Care, LLC	$4.6687 per EA	—	Generic	-3.51%	Penem Antibacterial
MEROPENEM IV 1 GM VIAL	44567040110	WG Critical Care, LLC	$4.6687 per EA	—	Generic	-3.51%	Penem Antibacterial
MEROPENEM IV 1 GM VIAL	55150020830	Eugia US LLC	$4.6687 per EA	—	Generic	-3.51%	Penem Antibacterial
MEROPENEM IV 1 GM VIAL	63323050830	Fresenius Kabi USA, LLC	$4.6687 per EA	—	Generic	-3.51%	Penem Antibacterial
MEROPENEM IV 1 GM VIAL	63323050831	Fresenius Kabi USA, LLC	$4.6687 per EA	—	Generic	-3.51%	Penem Antibacterial
MEROPENEM IV 1 GM VIAL	70121145307	Amneal Pharmaceuticals LLC	$4.6687 per EA	—	Generic	-3.51%	Penem Antibacterial
MEROPENEM IV 1 GM VIAL	70594007602	Xellia Pharmaceuticals USA LLC	$4.6687 per EA	—	Generic	-3.51%	Penem Antibacterial
MEROPENEM IV 1 GM VIAL	72485041210	Armas Pharmaceuticals Inc.	$4.6687 per EA	High Outlier	Generic	-3.51%	Penem Antibacterial
MEROPENEM IV 1 GM VIAL	72572041610	Civica, Inc.	$4.6687 per EA	—	Generic	-3.51%	Penem Antibacterial
MEROPENEM IV 500 MG VIAL	70121145407	Amneal Pharmaceuticals LLC	$2.8678 per EA	—	Generic	—	Penem Antibacterial
MEROPENEM IV 500 MG VIAL	55150020720	Eugia US LLC	$2.8678 per EA	—	Generic	—	Penem Antibacterial
MEROPENEM IV 500 MG VIAL	70594007502	Xellia Pharmaceuticals USA LLC	$2.8678 per EA	—	Generic	—	Penem Antibacterial
MEROPENEM IV 500 MG VIAL	72572041510	Civica, Inc.	$2.8678 per EA	—	Generic	—	Penem Antibacterial
MEROPENEM IV 500 MG VIAL	63323050720	Fresenius Kabi USA, LLC	$2.8678 per EA	—	Generic	—	Penem Antibacterial
MEROPENEM IV 500 MG VIAL	00143943010	Hikma Pharmaceuticals USA Inc.	$2.8678 per EA	—	Generic	—	Penem Antibacterial
MEROPENEM IV 500 MG VIAL	44567014510	WG Critical Care, LLC	$2.8678 per EA	—	Generic	—	Penem Antibacterial
MEROPENEM IV 500 MG VIAL	63323050721	Fresenius Kabi USA, LLC	$2.8678 per EA	—	Generic	—	Penem Antibacterial
MEROPENEM IV 500 MG VIAL	00781300095	Sandoz Inc.	$2.8678 per EA	—	Generic	—	Penem Antibacterial
MEROPENEM IV 500 MG VIAL	00409139051	Hospira Inc.	$2.8678 per EA	—	Generic	—	Penem Antibacterial
MEROPENEM IV 500 MG VIAL	44567040010	WG Critical Care, LLC	$2.8678 per EA	—	Generic	—	Penem Antibacterial
MEROPENEM IV 500 MG VIAL	00409022210	Hospira Inc.	$2.8678 per EA	—	Generic	—	Penem Antibacterial

Frequently Asked Questions

What is Meropenem used to treat?

When did Meropenem become available as a generic?

FDA approved the first generic Meropenem (ANDA) on Jun 22, 2010.

How much does Medicare spend on Meropenem?

In 2024, Medicare Part D spent $17 million on Meropenem across 94,000 claims for 30,000 beneficiaries.

How many Meropenem products are on the market?

The Meropenem drug market contains 25 NDCs from 10 manufacturers — 25 generic and 0 brand products.

What is the price range for Meropenem?

NADAC reference prices for Meropenem range from $2.8678 to $4.6687 per EA — a 63% difference between cheapest and most expensive.

Which manufacturers make Meropenem?

10 manufacturers list Meropenem in NADAC. Ranked by number of NDCs, the largest are Hospira Inc. (4), WG Critical Care, LLC (4), Fresenius Kabi USA, LLC (4), Hikma Pharmaceuticals USA Inc. (2), Sandoz Inc. (2).

How has the price of Meropenem changed recently?

Over the past 7 days, 0 Meropenem NDCs rose and 13 fell, with a market-wide average change of -3.5%.